Eiichi Kodama Selected Research

Enzymes

1/2008

Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eiichi Kodama Research Topics

Disease

7	Infections 07/2009 - 03/2006
2	HIV Infections (HIV Infection) 11/2009 - 01/2008
1	COVID-19 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2008
1	Glioma (Gliomas) 01/2006
1	Dengue (Dengue Fever) 05/2003

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 10/2008 - 09/2006
2	Antiviral Agents (Antivirals)IBA 11/2009 - 01/2008
2	NucleosidesIBA 01/2008 - 01/2007
1	Glycoproteins (Glycoprotein)IBA 07/2009
1	elvitegravirIBA 01/2008
1	EnzymesIBA 01/2008
1	Peptide Hydrolases (Proteases)FDA Link 01/2008
1	Peptides (Polypeptides)IBA 01/2008
1	Proteins (Proteins, Gene)FDA Link 01/2008
1	Reverse Transcriptase InhibitorsIBA 01/2008
1	L870810IBA 01/2008
1	LigandsIBA 09/2006
1	Chemokine ReceptorsIBA 09/2006
1	Chemokine CCL5IBA 09/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2006
1	QuinolonesIBA 03/2006
1	Indicators and Reagents (Reagents)IBA 01/2006
1	GalactosidasesIBA 01/2006
1	TitaniumIBA 05/2003
1	VanadiumIBA 05/2003

Therapy/Procedure

1	Personal Protective Equipment 01/2022
1	Highly Active Antiretroviral Therapy (HAART) 01/2008
1	Therapeutics 01/2008